Pfizer is dedicated to developing therapies to treat, slow, or prevent disease progression and improve the quality of life for patients with…

Vaccines are one of the greatest public health advancements of all time, resulting in the control, elimination, or near-elimination of numerous infectious diseases that were once pervasive and often fatal.

We want to transform the landscape of cancer treatment and significantly improve the lives of cancer patients worldwide.

Our goal is to transform chronic inflammatory diseases, many of which are poorly managed by existing treatments that provide only symptom relief.

Our rare disease team works to develop effective therapies for patients affected by rare disorders, which are defined by the EU as those diseases affecting fewer than 1 in 2000 patients.

Pfizer’s Hospital Business Unit currently offers large and diverse portfolios of anti-infectives and we’re a leader in sterile injectables and the emerging markets.